Antiviral Effects of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate Administered Orally Alone and in Combination to Woodchucks with Chronic Woodchuck Hepatitis Virus Infection
- 1 October 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (10) , 3617-3632
- https://doi.org/10.1128/aac.00654-08
Abstract
Adefovir dipivoxil (ADV) and tenofovir disoproxil fumarate (TDF) are nucleotide analogs that inhibit the replication of wild-type hepatitis B virus (HBV) and lamivudine (3TC)-resistant virus in HBV-infected patients, including those who are coinfected with human immunodeficiency virus. The combination of ADV or TDF with other nucleoside analogs is a proposed strategy for managing antiviral drug resistance during the treatment of chronic HBV infection. The antiviral effect of oral ADV or TDF, alone or in combination with 3TC or emtricitabine (FTC), against chronic woodchuck hepatitis virus (WHV) infection was evaluated in a placebo-controlled study in the woodchuck, an established and predictive model for antiviral therapy. Once-daily treatment for 48 weeks with ADV plus 3TC or TDF plus FTC significantly reduced serum WHV viremia levels from the pretreatment level by 6.2 log10and 6.1 log10genome equivalents/ml serum, respectively, followed by TDF plus 3TC (5.6 log10genome equivalents/ml), ADV alone (4.8 log10genome equivalents/ml), ADV plus FTC (one survivor) (4.4 log10genome equivalents/ml), TDF alone (2.9 log10genome equivalents/ml), 3TC alone (2.7 log10genome equivalents/ml), and FTC alone (2.0 log10genome equivalents/ml). Individual woodchucks across all treatment groups also demonstrated pronounced declines in serum WHV surface antigen, characteristically accompanied by declines in hepatic WHV replication and the hepatic expression of WHV antigens. Most woodchucks had prompt recrudescence of WHV replication after drug withdrawal, but individual woodchucks across treatment groups had sustained effects. No signs of toxicity were observed for any of the drugs or drug combinations administered. In conclusion, the oral administration of 3TC, FTC, ADV, and TDF alone and in combination was safe and effective in the woodchuck model of HBV infection.Keywords
This publication has 71 references indexed in Scilit:
- Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutationsJournal of Hepatology, 2008
- Antiviral Effect of Orally Administered (−)-β-d-2-Aminopurine Dioxolane in Woodchucks with Chronic Woodchuck Hepatitis Virus InfectionAntimicrobial Agents and Chemotherapy, 2007
- Adefovir Dipivoxil Alone or in Combination with Lamivudine for Three Months in Patients with Lamivudine Resistant Compensated Chronic Hepatitis BDigestive Diseases and Sciences, 2007
- Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with responseJournal of Viral Hepatitis, 2006
- Antiviral Effect of Oral Administration of Tenofovir Disoproxil Fumarate in Woodchucks with Chronic Woodchuck Hepatitis Virus InfectionAntimicrobial Agents and Chemotherapy, 2005
- Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failureJournal of Hepatology, 2005
- Rapid hepatitis B virus-DNA decay in co-infected HIV–hepatitis B virus ‘e-minus’ patients with YMDD mutations after 4 weeks of tenofovir therapyAIDS, 2003
- Tenofovir Disoproxil Fumarate Therapy for Chronic Hepatitis B in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Individuals for Whom Interferon‐α and Lamivudine Therapy Have FailedThe Journal of Infectious Diseases, 2002
- Treatment of recurrent hepatitis B infection in liver transplant recipientsLiver Transplantation, 2002
- Long-Term Entrainment of Circannual Reproductive and Metabolic Cycles by Northern and Southern Hemisphere Photoperiods in Woodchucks (Marmota monax)1Biology of Reproduction, 1997